BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11003504)

  • 21. Design for an accelerator-based orthogonal epithermal neutron beam for boron neutron capture therapy.
    Allen DA; Beynon TD; Green S
    Med Phys; 1999 Jan; 26(1):71-6. PubMed ID: 9949400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of the prompt-gamma neutron activation facility at Brookhaven National Laboratory.
    Dilmanian FA; Lidofsky LJ; Stamatelatos I; Kamen Y; Yasumura S; Vartsky D; Pierson RN; Weber DA; Moore RI; Ma R
    Phys Med Biol; 1998 Feb; 43(2):339-49. PubMed ID: 9509530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a new IRSN thermal neutron field facility using Monte-Carlo simulations.
    Lacoste V
    Radiat Prot Dosimetry; 2007; 126(1-4):58-63. PubMed ID: 17578877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calibration of the delayed-gamma neutron activation facility.
    Ma R; Zhao X; Rarback HM; Yasumura S; Dilmanian FA; Moore RI; Lo Monte AF; Vodopia KA; Liu HB; Economos CD; Nelson ME; Aloia JF; Vaswani AN; Weber DA; Pierson RN; Joel DD
    Med Phys; 1996 Feb; 23(2):273-7. PubMed ID: 8668109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility study on epithermal neutron field for cyclotron-based boron neutron capture therapy.
    Yonai S; Aoki T; Nakamura T; Yashima H; Baba M; Yokobori H; Tahara Y
    Med Phys; 2003 Aug; 30(8):2021-30. PubMed ID: 12945968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerator-based epithermal neutron beam design for neutron capture therapy.
    Yanch JC; Zhou XL; Shefer RE; Klinkowstein RE
    Med Phys; 1992; 19(3):709-21. PubMed ID: 1324392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An optimized neutron-beam shaping assembly for accelerator-based BNCT.
    Burlon AA; Kreiner AJ; Valda AA; Minsky DM
    Appl Radiat Isot; 2004 Nov; 61(5):811-5. PubMed ID: 15308149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRELIMINARY STUDY OF NEUTRON FIELD IN TOP-IMPLART PROTON THERAPY BEAM.
    Ferrari P; Vadrucci M; Ampollini A; Campani L; Picardi L; Ronsivalle C; Mariotti F
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):360-364. PubMed ID: 29053837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of (41)Ar production in 0.1-1.1.0-GeV proton accelerator vaults using FLUKA Monte Carlo code.
    Biju K; Sunil C; Sarkar PK
    Radiat Prot Dosimetry; 2013 Dec; 157(3):437-41. PubMed ID: 23754833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMPREHENSIVE RADIATION DOSE MEASUREMENTS AND MONTE CARLO SIMULATION FOR THE 7Li(p,n) ACCELERATOR NEUTRON FIELD.
    Darvish-Molla S; Prestwich WV; Byun SH
    Radiat Prot Dosimetry; 2016 Dec; 171(4):421-430. PubMed ID: 26464524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a phantom equivalent to measure bone-fluorine in a human's hand via delayed neutron activation analysis.
    Mostafaei F; McNeill FE; Chettle DR; Prestwich WV; Inskip M
    Physiol Meas; 2013 May; 34(5):503-12. PubMed ID: 23587669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerator driven neutron source design via beryllium target and
    Khorshidi A
    J Cancer Res Ther; 2017; 13(3):456-465. PubMed ID: 28862209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and simulation of a neutron facility.
    Studenski MT; Kearfott KJ
    Health Phys; 2007 Feb; 92(2 Suppl):S37-44. PubMed ID: 17228186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fast response and gamma-insensitive neutron detector based on parallel-plate avalanche counter.
    Nakhostin M; Baba M; Itoga T; Oishi T; Unno Y; Kamada S; Okuji T
    Radiat Prot Dosimetry; 2008; 129(4):426-30. PubMed ID: 17998200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bremsstrahlung and photoneutron production in a steel shield for 15-22-MeV clinical electron beams.
    Fujita Y; Myojoyama A; Saitoh H
    Radiat Prot Dosimetry; 2015 Feb; 163(2):148-59. PubMed ID: 24821930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benchmarking of activation reaction distribution in an intermediate energy neutron field.
    Ogawa T; Morev MN; Hirota M; Abe T; Koike Y; Iwai S; Iimoto T; Kosako T
    Radiat Prot Dosimetry; 2011 Jul; 146(1-3):356-9. PubMed ID: 21515619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monte Carlo simulations for the shielding of the future high-intensity accelerator facility FAIR at GSI.
    Radon T; Gutermuth F; Fehrenbacher G
    Radiat Prot Dosimetry; 2005; 115(1-4):212-5. PubMed ID: 16381714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical Note: On maximizing Cherenkov emissions from medical linear accelerators.
    Shrock Z; Yoon SW; Gunasingha R; Oldham M; Adamson J
    Med Phys; 2018 Jul; 45(7):3315-3320. PubMed ID: 29672860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of an accelerator based system for in vivo aluminium measurement in peripheral bone.
    Green S; Bradley DA; Mountford PJ; Morgan WD; Chettle DR; Weaver DR
    Basic Life Sci; 1993; 60():289-93. PubMed ID: 8110130
    [No Abstract]   [Full Text] [Related]  

  • 40. Characteristics of high-energy neutrons estimated using the radioactive spallation products of Au at the 500-MeV neutron irradiation facility of KENS.
    Matsumura H; Masumoto K; Nakao N; Wang Q; Toyoda A; Kawai M; Aze T; Fujimura M
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):1-5. PubMed ID: 16604584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.